These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 5899882)

  • 1. Correlations between behavior of schizophrenic patients and the urinary excretions of indoles, catechols and steroids.
    Himwich HE
    Folia Psychiatr Neurol Jpn; 1965; 19(4):326-45. PubMed ID: 5899882
    [No Abstract]   [Full Text] [Related]  

  • 2. Excretion of urinary indoles in patients with recurrent dreams.
    Kalter S; Metzger H; Todd W; DiGiorgi F
    Dis Nerv Syst; 1968 Mar; 29(3):182-8. PubMed ID: 5674955
    [No Abstract]   [Full Text] [Related]  

  • 3. Schizophrenic behavior and urinary tryptophan metabolites associated with cysteine given with and without a monoamine oxidase inhibitor (tranylcypromine).
    Spaide J; Tanimukai H; Ginther R; Bueno J; Himwich HE
    Life Sci; 1967 Mar; 6(5):551-60. PubMed ID: 4226702
    [No Abstract]   [Full Text] [Related]  

  • 4. Methionine and tryptophan loading in schizophrenic patients receiving a MAO inhibitor: correlation of behavioral and biochemical changes.
    Spaide J; Neveln L; Tolentino J; Himwich HE
    Biol Psychiatry; 1969 Jul; 1(3):227-33. PubMed ID: 5352654
    [No Abstract]   [Full Text] [Related]  

  • 5. URINARY TRYPTAMINE AND INDOLE-3-ACETIC ACID EXCRETION BY SCHIZOPHRENIC PATIENTS: USE OF THE TRYPTAMINE/INDOLE ACETIC ACID RATIO AS AN INDEX OF MONOAMINE OXIDASE INHIBITION.
    LABROSSE EH; KOPIN IJ; FELIX WR; WESTLAKE RJ
    J Psychiatr Res; 1964 Oct; 2():185-97. PubMed ID: 14242376
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparative behavioral and biochemical effects of tranylcypromine and cysteine on normal controls and schizophrenic patients.
    Narasimhachari N; Heller B; Spaide J; Haskovec L; Fujimori M; Tabushi K; Himwich HE
    Life Sci I; 1970 Sep; 9(18):1021-32. PubMed ID: 5478406
    [No Abstract]   [Full Text] [Related]  

  • 7. Thin layer chromatography of indolyl-acrylyl-glycine and other urinary indoles.
    Hansen IL; Crawford MA
    J Chromatogr; 1966 May; 22(2):330-5. PubMed ID: 4960113
    [No Abstract]   [Full Text] [Related]  

  • 8. Separation of phenolic and indolic acids from untreated urine.
    Saini AS
    J Chromatogr; 1971 Feb; 54(3):442-5. PubMed ID: 5546379
    [No Abstract]   [Full Text] [Related]  

  • 9. ENDOGENOUS METABOLIC FACTOR IN SCHIZOPHRENIC BEHAVIOR.
    BERLET HH; BULL C; HIMWICH HE; KOHL H; MATSUMOTO K; PSCHEIDT GR; SPAIDE J; TOURLENTES TT; VALVERDE JM
    Science; 1964 Apr; 144(3616):311-3. PubMed ID: 14169724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary exeretion of phenolic and indolic compounds, metacatecholamines, and VMA by full-term and premature infants.
    Nicolopoulos D; Agathopoulos A; Danelatou-Athanassiadou C; Bafataki M
    Pediatrics; 1968 Apr; 41(4):777-83. PubMed ID: 5300700
    [No Abstract]   [Full Text] [Related]  

  • 11. Correlations between behavior and urinary excretion of indole amines and catecholamines in schizophrenic patients as affected by drugs.
    BRUNE GG; PSCHEIDT GR
    Fed Proc; 1961 Dec; 20():889-93. PubMed ID: 13873986
    [No Abstract]   [Full Text] [Related]  

  • 12. The urinary output of catecholamines in narcolepsy under resting conditions and following administration of dopamine, DOPA, and DOPS.
    Gunne LM; Lidvall HF
    Scand J Clin Lab Invest; 1966; 18(4):425-30. PubMed ID: 5950129
    [No Abstract]   [Full Text] [Related]  

  • 13. Urinary studies of schizophrenics and controls.
    Narasimhachari N; Heller B; Spaide J; Haskovec L; Fujimori M; Tabushi K; Himwich HE
    Biol Psychiatry; 1971; 3(1):9-20. PubMed ID: 4398666
    [No Abstract]   [Full Text] [Related]  

  • 14. [Inhibition of monoamine oxidase and diamine oxidase by furazolidone (Furoxon). Pharmacologic and biochemical studies in man].
    Palm D; Magnus U
    Klin Wochenschr; 1968 Jul; 46(13):720-8. PubMed ID: 4389812
    [No Abstract]   [Full Text] [Related]  

  • 15. Urinary indoleamines in Tourette syndrome patients with obsessive-compulsive characteristics.
    Bornstein RA; Baker GB
    Psychiatry Res; 1992 Mar; 41(3):267-74. PubMed ID: 1375759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet and plasma amine oxidase inhibition and urinary amine excretion changes during phenelzine treatment.
    Murphy DL; Brand E; Goldman T; Baker M; Wright C; van Kammen D; Gordon E
    J Nerv Ment Dis; 1977 Feb; 164(2):129-34. PubMed ID: 836485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Observations on the effect of ethanol on the urinary excretion of histamine, 5-hydroxyindole acetic acid, catecholamines and 17-hydroxycorticosteroids in man.
    PERMAN ES
    Acta Physiol Scand; 1961 Jan; 51():62-7. PubMed ID: 13734444
    [No Abstract]   [Full Text] [Related]  

  • 18. Biochemical correlates of behavior in schizophrenic patients. Schizophrenic patients receiving tryptophan and methionine or methionine together with a monoamine oxidase inhibitor.
    Berlet HH; Matsumoto K; Pscheidt GR; Spaide J; Bull C; Himwich HE
    Arch Gen Psychiatry; 1965 Dec; 13(6):521-31. PubMed ID: 5841751
    [No Abstract]   [Full Text] [Related]  

  • 19. Analysis for indole compounds in urine by high-performance liquid chromatography with fluorometric detection.
    Graffeo AP; Karger BL
    Clin Chem; 1976 Feb; 22(2):184-7. PubMed ID: 2390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Indoleamine metabolism in affective disorders: excretion of tryptamine, indoleacetic acid and 5-hydroxy-indoleacetic acid in depressive states.
    McNamee HB; Moody JP; Naylor GJ
    J Psychosom Res; 1972 Feb; 16(1):63-70. PubMed ID: 5058989
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.